Page last updated: 2024-10-29

iohexol and Tuberculosis, Multidrug-Resistant

iohexol has been researched along with Tuberculosis, Multidrug-Resistant in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Tuberculosis, Multidrug-Resistant: Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, ES1
Park, CM1
Goo, JM1
Yim, JJ1
Kim, HR1
Lee, HJ1
Lee, IS1
Im, JG1

Other Studies

1 other study available for iohexol and Tuberculosis, Multidrug-Resistant

ArticleYear
Computed tomography features of extensively drug-resistant pulmonary tuberculosis in non-HIV-infected patients.
    Journal of computer assisted tomography, 2010, Volume: 34, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bronchial Diseases; Contrast Media; Drug Resistance, Bac

2010